Immuron Limited Gains 24.44%
Wed, Nov 11, 2020 at 05:30 PM
Immuron Limited (IMRN:NASDAQ) shot up at $8.4, a gain of 24.4%. The stock appeared on our News Catalysts scanner on Wed 11 Nov 20 at 08:13 AM in the 'BIOTECH' category. From Tue 27 Oct 20, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Tue 09 Jun 20 at $28.99 with a volume of 75M+, and its share price has been moving sideways in recent weeks.
About Immuron Limited (IMRN:NASDAQ)
Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.
Top 10 Gainers:
- Five Prime Therapeutics, Inc. (FPRX:NASDAQ), 237.08%
- Fuel Tech, Inc. (FTEK:NASDAQ), 64.26%
- Equillium, Inc. (EQ:NASDAQ), 44.83%
- GRAY (GRAY:NASDAQ), 35.27%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 34.66%
- Genfit SA (GNFT:NASDAQ), 28.79%
- Immuron Limited (IMRN:NASDAQ), 24.44%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 24.02%
- Revlon, Inc. (REV:NYSE), 22.53%
- Celcuity Inc. (CELC:NASDAQ), 22.03%